Director, DP Workstream Leader – Small Molecule Parenteral (LAIs and Oligos)
Leads late-stage drug product development for sterile long-acting injectables and oligonucleotides, guiding cross-functional teams in formulation, process development, and technology transfer. Translates CMC and regulatory strategies into actionable plans, ensuring robust control strategies and compliance across clinical and commercial phases. Works within a matrix environment to align R&D, manufacturing, and supply chain functions for successful asset delivery.